Filing Details

Accession Number:
0001250853-21-000066
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-06-17 21:30:55
Reporting Period:
2021-06-16
Accepted Time:
2021-06-17 21:30:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1561743 Kindred Biosciences Inc. KIN () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1337252 Richard Chin C/O Kindred Biosciences, Inc.
1555 Bayshore Highway, Suite 200
Burlingame CA 94010
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-06-16 40,000 $9.18 1,934,271 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 22, 2020.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.165 to $9.19, inclusive. The reporting person undertakes to provide to Kindred Biosciences, Inc., any security holder of Kindred Biosciences, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.